Herpimax 800 Tablet DT contains Acyclovir 800 mg, an antiviral agent indicated for the treatment of infections caused by herpes simplex virus types 1 and 2, including genital herpes, cold sores, and herpes labialis. It is also effective in managing varicella-zoster virus infections such as shingles and chickenpox. Acyclovir acts by inhibiting viral DNA synthesis, thereby limiting viral replication and reducing the severity and duration of symptoms. Herpimax 800 Tablet DT is formulated as a dispersible tablet, facilitating rapid dissolution and ease of administration, particularly beneficial for patients with swallowing difficulties. The recommended dosage and duration of therapy depend on the type and severity of the infection, as well as patient-specific factors such as renal function. Common adverse effects may include headache, nausea, diarrhea, and occasional skin rash. Caution is advised in patients with renal impairment, and adequate hydration should be maintained to prevent renal toxicity. Herpimax 800 Tablet DT should be used under medical supervision, and patients are advised to complete the full course of therapy to prevent viral resistance. It is contraindicated in individuals with known hypersensitivity to acyclovir or valacyclovir. This medication does not cure herpes infections but helps to control symptoms and reduce viral shedding.